• AI-enabled ECGs may identify patients at

    From ScienceDaily@1:317/3 to All on Mon May 2 22:30:40 2022
    AI-enabled ECGs may identify patients at greater risk of stroke,
    cognitive decline

    Date:
    May 2, 2022
    Source:
    Mayo Clinic
    Summary:
    Atrial fibrillation, the most common cardiac rhythm abnormality,
    has been linked to one-third of ischemic strokes, the most common
    type of stroke.

    But atrial fibrillation is underdiagnosed, partly because many
    patients are asymptomatic.



    FULL STORY ========================================================================== Atrial fibrillation, the most common cardiac rhythm abnormality, has
    been linked to one-third of ischemic strokes, the most common type of
    stroke. But atrial fibrillation is underdiagnosed, partly because many
    patients are asymptomatic.


    ========================================================================== Artificial intelligence-enabled electrocardiography (ECG) was recently
    shown to identify the presence of brief episodes of atrial fibrillation,
    and the ability of an AI-enabled ECG algorithm to predict atrial
    fibrillation up to 10 years before clinical diagnosis has been confirmed
    in a population-based study conducted by Mayo Clinic researchers.

    A new population-based study from Mayo Clinic now offers evidence that
    the algorithm can help identify patients at greater risk of cognitive
    decline. AI- enabled ECG that shows high probability of atrial
    fibrillation also was associated with the presence of infarctions,
    or incidents of cerebral stroke, on MRI, according to the study.

    The study is described in an article, "Artificial Intelligence-Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive
    Decline Risk and Cerebral Infarcts," which is published in Mayo Clinic Proceedings.

    Most of the infarctions observed were subcortical, meaning that they
    occurred in the region of the brain below the cortex. This suggests
    that AI-enabled ECG not only predicts atrial fibrillation, but also
    detects other cardiac disease markers and correlates with small vessel cerebrovascular disease and cognitive decline.

    "This study finds that artificial intelligence-enabled electrocardiography acquired during normal sinus rhythm was associated with worse baseline cognition and gradual decline in global cognition and attention," says
    Jonathan Graff-Radford, M.D., a Mayo Clinic neurologist and the study's corresponding author. "The findings raise the question whether initiation
    of anticoagulation is an effective and safe preventive strategy in
    individuals with a high AI-ECG algorithm score for reducing the risk
    of stroke and cognitive decline." Prospective controlled studies are
    needed to determine whether a high atrial fibrillation score on an
    AI-enabled electrocardiogram could be a biomarker to identify patients
    for anticoagulation or more aggressive stroke risk factor modification,
    Dr. Graff-Radford says.

    The retrospective study reviewed sinus-rhythm ECG of 3,729 patients
    with a median age of 74 years who were enrolled in the Mayo Clinic Study
    of Aging between 2004 and 2020. Adjusting for demographic factors, the AI-enabled ECG atrial fibrillation score correlated with lower baseline
    and faster decline in global cognitive scores. About one-third of the
    patients who underwent ECG also had an MRI, and high atrial fibrillation probability in the ECG correlated with MRI-detected cerebral infarcts.

    "Application of this AI-ECG algorithm may be another way to screen
    individuals not only to determine risk of atrial fibrillation, but
    also to identify future risk of cognitive decline and stroke," says
    Dr. Graff-Radford.

    Research reported in the article was supported by grants from the National Institute on Aging and the National Institutes of Health. The study was
    made possible by the Rochester Epidemiology Project. Potential competing interests are identified in the article. Among the potential competing interests, Peter Noseworthy, M.D., a Mayo Clinic cardiologist, and Mayo
    Clinic have filed patents related to the application of AI to ECG for
    diagnosis and risk stratification.


    ========================================================================== Story Source: Materials provided by Mayo_Clinic. Original written by
    Jay Furst. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Erika L. Weil, Peter A. Noseworthy, Camden L. Lopez, Alejandro A.

    Rabinstein, Paul A. Friedman, Zachi I. Attia, Xiaoxi Yao,
    Konstantinos C.

    Siontis, Walter K. Kremers, Georgios Christopoulos, Michelle
    M. Mielke, Prashanthi Vemuri, Clifford R. Jack, Bernard J. Gersh,
    Mary M. Machulda, David S. Knopman, Ronald C. Petersen, Jonathan
    Graff-Radford. Artificial Intelligence-Enabled Electrocardiogram
    for Atrial Fibrillation Identifies Cognitive Decline Risk and
    Cerebral Infarcts. Mayo Clinic Proceedings, 2022; 97 (5): 871 DOI:
    10.1016/j.mayocp.2022.01.026 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2022/05/220502120505.htm

    --- up 9 weeks, 10 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)